propagermanium has been researched along with Experimental Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suzuki, F | 2 |
2 other study(ies) available for propagermanium and Experimental Leukemia
| Article | Year |
|---|---|
[Ability of sera from mice treated with Ge-132, an organo-germanium compound, to inhibit experimental murine ascites tumors].
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Germanium; Immunization, Passive; Interferon-gamma; Leukemia, Experimental; Macrophage Activation; Mice; Mice, Inbred BALB C; Organometallic Compounds; Propionates | 1985 |
[Suppression of tumor growth by peritoneal macrophages isolated from mice treated with carboxyethylgermanium sesquioxide (Ge-132)].
Topics: Administration, Oral; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cytotoxicity, Immunologic; Germanium; Leukemia, Experimental; Liver Neoplasms, Experimental; Macrophage Activation; Macrophages; Mice; Organometallic Compounds; Peritoneal Cavity; Propionates | 1985 |